Very Important Histopathological Factors in Patients with Resected Non-Small Cell Lung Cancer: Necrosis and Perineural Invasion

Abstract

Background: The current staging system provides an anatomical classification of lung tumors; its secondary purpose is to allow the prognostic stratification of patients into homogeneous groups after surgery. In this work, intratumoral perineural invasion, lymphatic and blood vessel invasion together with the necrosis content of the tumor exclusive of the non-small cell cancer staging system were studied. Methods: During a 4-year period, 152 patients operated for non-small cell lung cancer (NSCLC) at our hospital were analyzed. Mean age of patients was 55.7 ± 10.1 years. Results: Overall 5-year survival was 42.2 %. Mediastinal lymph node involvement, tumor size, incomplete resection, pneumonectomy, presence of necrosis and perineural invasion were significant prognosticators (p = 0.03, 0.04, 0.0001, 0.046, 0.0246, < 0.0001, respectively). Multivariate analysis revealed that N status, perineural invasion, and the presence of necrosis were independent prognostic factors (p = 0.006, p = 0.001, p = 0.001, respectively). Patients who had stage I tumor with necrosis and perineural invasion had a lower survival rate than those with stage IIIA tumor without these histopathological features (p = 0.04). The presence of these histopathological characteristics in stage IIIA patients was a sign of a poorer prognosis (p = 0.0001). Conclusions: Perineural invasion and the presence of necrosis independently indicated a dismal prognosis and their prognostic power is comparable to those of the TNM classification. These factors could be candidates for better survival stratification and the indicators of the need for adjuvant therapy in early stage lung cancer patients.

Key words

thoracic surgery - staging - histopathological factors - resection

References

• 1 Hammer E M. TNM classification of malignant tumors. Geneva; Union Internationale Contre le Cancer 1978: 41-45
• 2 Mountain C F. Revisions in the international system for staging lung cancer.  Chest. 1997;  111 1710
• 3 Non-Small Cell Lung Cancer Collaborative Group . Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials.  BMJ. 1995;  311 899-905
• 4 Nesbitt J C, Putnam Jr J B, Walsh G L, Walsh G L, Roth J A, Mountain C F. Survival in early-stage non-small cell lung cancer.  Ann Thorac Surg. 1995;  60 466-472
• 5 Hilsenbeck S G, Raub W A, Sridhar K S. Prognostic factors in lung cancer based on multivariate analysis.  Am J Clin Oncol. 1993;  16 301-309
• 6 Fujisawa T, Yamaguchi Y, Saitoh Y, Hiroshima K, Ohwada H. Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected non-small cell carcinoma of the lung with intrapulmonary metastases.  Cancer. 1995;  76 2464-2470
• 7 Rigau V, Molina T J, Chaffaud C, Huchon G, Audoin J, Chevret S, Brechot J M. Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence.  Lung Cancer. 2002;  38 169-176
• 8 World Health Organization .International histological classification of tumours. 3rd ed. Berlin, Heidelberg; Springer Verlag 1999
• 9 Mountain C F, Dresler C M. Regional lymph node classification for lung cancer staging.  Chest. 1997;  111 1718-1723
• 10 Cicero J L, Ponn R B, Daly D T. Surgical treatment of non-small cell lung cancer. Shields TW General thoracic surgery. 5th ed. Philadelphia; Lippincott Williams & Wilkins 2000: 1311-1341
• 11 Mountain C F. New prognostic factors in lung cancer. Biologic prophets of cancer cell aggression.  Chest. 1995;  108 246-254
• 12 O'Byrne K J, Cox G, Swinson D, Richardson D, Edwards J G, Lolljee J, Andi A, Koukourakis M I, Giatromanolaki A, Gatter K, Harris A L, Waller D, Jones J L. Towards a biological staging model for operable non-small cell lung cancer.  Lung Cancer. 2001;  34 (Suppl. 2) S83-S89
• 13 Putnam J B. The anatomic basis for lung cancer staging: the end of the beginning?.  Ann Thorac Surg. 2001;  71 1757-1758
• 14 Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Yokose T, Nishiwaki Y. Conventional clinicopathologic factors in surgically resected non-small cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses.  Cancer. 1999;  86 1976-1984
• 15 Fu X L, Zhu X Z, Shi D R, Xiu L Z, Wang L J, Zhao S, Qian H, Lu H F, Xiang Y B, Jiang G L. Study of prognostic predictors for non-small cell lung cancer.  Lung Cancer. 1999;  23 143-152
• 16 Sayar A, Turna A, Solak O, Kılıçgün A, Ürer N, Gürses A. Non-anatomic prognostic factors in resected non-small cell lung carcinoma: the importance of perineural invasion as a new prognostic marker.  Ann Thorac Surg. 2004;  77 421-425
• 17 Shirouzu K, Isomoto H, Kakegawa T. Prognostic evaluation of perineural invasion in rectal cancer.  Am J Surg. 1993;  165 233-237
• 18 Nangia A K, Konety B R, Wachtel S, Dhir R, Becich M J, Bahnson P R. Perineural invasion in transitional cell carcinoma and the effect on prognosis following radical cystectomy.  Urology. 1997;  49 968-972
• 19 Ozaki H, Hiraoka T, Mizumoto R, Matsuno S, Matsumoto Y, Nakayama T, Tsunoda T, Suzuki T, Monden M, Saitoh Y, Yamauchi H, Ogata Y. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection.  Surg Today. 1999;  29 16-22
• 20 Maru N, Ohori M, Kattan M W, Scardino P T, Wheeler T M. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.  Hum Pathol. 2001;  32 828-833
• 21 Margolese R G, Fısher B, Hortobagy G N, Bloomer W D. Neoplasms of the breast. Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E Cancer medicine. London; B. C. Decker Inc. 2000: 1747
• 22 Khan O A, Fitzgerald J J, Field M L, Soomro I, Soomro I, Beggs F D, Morgan W E, Duffy J P. Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung.  Ann Thorac Surg. 2004;  77 1173-1178
• 23 Goldstraw P, Crowley J J. The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer.  J Thorac Oncol. 2007;  1 281-286
• 24 Robinson L A, Ruckdeschel J C, Wagner H, Stevens Jr C W. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).  Chest. 2007;  132 243-265
• 25 Scott W J, Howington J, Feigenberg S, Movsas B, Pisters K. Treatment of non-small cell lung cancer stage I and stage II.  Chest. 2007;  132 234S-242S